Replies to post #448032 on Anavex Life Sciences Corp (AVXL)

[powerwalker]

Wishful thinking!

[BAR123]

I disagree. If the publisher is of a top tier nature, meaning NEJM or something similar and it clearly shows that 2-73 has the best results, we skyrocket. At least we should get to a $3-$4B market cap. Then the shorts attack again bringing it back down so that the true biotech funds can get in. They are in it for $100pps + so buying in at $25 is not so bad after we are truly de-risked.